Abstract
Aim: While infusing reconstituted high-density lipoproteins (rHDL) has been demonstrated to have favorable effects on lipid transport, vascular function and plaque prior to the use of intensive statin therapy, the impact of CER-001, a pre-beta high-density lipoprotein (HDL) mimetic containing sphingomyelin and dipalmitoyl phosphatidlyglycerol is uncertain.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
